Grundsätze jüdischer Erziehung : einleitender Vortrag d. Erziehungswoche zu Nürnberg am 29. April

von Max Freudenthal

Concert für die Clarinette : mit Orchester- od. Pianoforte-Begleitung ; op. 29

componirt von Julius Rietz

Rechenschafts-Bericht des Ausschusses des Vereins zur Versorgung armer israelitischer Waisen und verwahrloster Kinder, erstattet am 27/29. September 1835, bei der öffentlichen Aufnahme der Pflege im Saale des Museums zu Stuttgart

[Bearb.[[Elektronische Ressource]] : Carl Weil]

Die Juden in Franken : ein unpartheiischer Beitrag zur Sitten- und Rechtsgeschichte Frankens ; mit 29 Urkunden-Beil.

von L. Heffner

Gerichtlicher Proceß und Urtheil deß Parlaments zu Metz eines Juden Raphael Levi genandt wegen eines von ihme den 29. Septembr. 1669 geraubten und hingerichteten drey jährigen Kindes : auß dem zu Metz gedrucktem Französischen Exemplar ins Teutsche übersetztet

Text [Extract] franz. und dt.

Mindeskrift i anledning af hundredaarsdagen for anordningen af 29. marts 1814 en fremstelling af jødiske rets-og livsforhold i udland og indland navnlig i tiden omkring aar 1800 : med an samling arkivalia

Julius Salomon og Josef Fischer. Udgivet af Danmark Loge u. O. B. No. 712

Clinical experience with the freedom SOLO stentless aortic valve in 277 consecutive patients.

BACKGROUND The Sorin Freedom SOLO (FS) bovine pericardial stentless valve prosthesis is designed for supraannular, subcoronary implantation. We report our experience and results with 277 consecutively implanted FS bioprostheses. METHODS 277 patients (mean age, 74.2 ± 7.3 years; 139 (50.2%) female) underwent aortic valve replacement (AVR) with the FS stentless bioprosthesis. The hemodynamic performance was investigated with transthoracic echocardiography at discharge, 6 months later, and yearly thereafter. Follow-up was 100% complete, with an average observation time of 2.6 ± 1.7 years and a total of 697.3 patient-years. RESULTS The overall 30-day mortality was 4.3%. The mortalities for isolated AVR and combined procedures were 1.9% and 7.3%, respectively. No causes of death were valve-related. Preoperative peak (74.2 ± 23.0 mm Hg) and mean (48.6 ± 16.3 mm Hg) gradients decreased to 15.6 ± 5.4 mm Hg and 8.8 ± 3.0 mm Hg postoperatively and remained unchanged for as long as 5 years. The postoperative mean effective orifice area (EOA) for valve sizes 19, 21, 23, 25, and 27 were 1.49 ± 0.32 cm(2), 1.67 ± 0.40 cm(2), 1.92 ± 0.38 cm(2), 2.01 ± 0.42 cm(2), and 2.13 ± 0.36 cm(2), respectively. Severe prosthesis-patient mismach (PPM) was completely absent, and moderate PPM occurred in 17 patients (6.1%). In isolated AVR, 0.8% of patients with preoperative sinus rhythm required a permanent pacemaker before hospital discharge. There was 100% freedom from structural valve deterioration, 99.6 % freedom from endocarditis and reoperation, and 97.3% freedom from thromboembolism at 5 years. CONCLUSIONS The FS stentless aortic valve is safe to implant, and it shows excellent hemodynamic performance and early and midterm results. Owing to the favorable EOA, the valve appears particularly attractive for patients at risk for PPM.

Festschrift Professor Dr. Maybaum zum 70. Geburtstag : (29. April 1914)

gewidmet von seinen Schülern